Switch to:
GuruFocus has detected 4 Warning Signs with Alexion Pharmaceuticals Inc $ALXN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Alexion Pharmaceuticals Inc (NAS:ALXN)
Accounts Payable & Accrued Expense
$572 Mil (As of Dec. 2016)

Alexion Pharmaceuticals Inc's quarterly accounts payable & accrued expense increased from Jun. 2016 ($436 Mil) to Sep. 2016 ($530 Mil) and increased from Sep. 2016 ($530 Mil) to Dec. 2016 ($572 Mil).

Alexion Pharmaceuticals Inc's annual accounts payable & accrued expense increased from Dec. 2014 ($439 Mil) to Dec. 2015 ($460 Mil) and increased from Dec. 2015 ($460 Mil) to Dec. 2016 ($572 Mil).


Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Alexion Pharmaceuticals Inc Annual Data

Accounts Payable & Accrued Expense 378078123178228424439460572

Alexion Pharmaceuticals Inc Quarterly Data

Accounts Payable & Accrued Expense 301439361454405460402436530572
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)